Why Do Some Recovered Peripartum Cardiomyopathy Mothers Experience Heart Failure With a Subsequent Pregnancy?

被引:17
|
作者
Fett J.D. [1 ,2 ,4 ]
Shah T.P. [3 ]
McNamara D.M. [1 ]
机构
[1] Investigations of Pregnancy Associated Cardiomyopathy (IPAC), Peripartum Cardiomyopathy Network of North America (PCN), Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
[2] Department of Adult Medicine, Hospital Albert Schweitzer, Deschapelles
[3] Baylor College of Medicine, Houston, TX
[4] 2331 Mt. Hood Court SE, Lacey, 98503, WA
关键词
Biomarkers; Echocardiography; Heart failure; Outcomes; Peripartum cardiomyopathy; PPCM; Subsequent pregnancy;
D O I
10.1007/s11936-014-0354-x
中图分类号
学科分类号
摘要
After concerns about survival and recovery from peripartum cardiomyopathy (PPCM), the question commonly asked is, “Is it safe to have another pregnancy?” While important advances have been made in the past decade in the recognition and treatment of PPCM, we still do not know why some apparently recovered PPCM mothers have a relapse of heart failure in a subsequent pregnancy. Knowing that some risk for relapse is always present, careful monitoring of the post-PPCM pregnancy is currently the best way to enable earlier diagnosis with institution of effective evidence-based treatment. In that situation it is reassuring to observe that when a subsequent pregnancy begins with recovered left ventricular systolic function to echocardiographic ejection fraction ≥0.50, even with relapse, the response to treatment is good with much more favorable outcomes. On the other hand, beginning the subsequent pregnancy with echocardiographic ejection fraction <0.50 greatly increases the risk for less favorable outcomes. This article summarizes the current state of knowledge; addresses the important questions facing patients, their families, and caregivers; and identifies the need for a prospective multi-center study of women with post-PPCM pregnancies. The reality is that an estimated 10 % to 20 % of apparently recovered PPCM mothers are going to relapse in a post-PPCM pregnancy; but we do not yet know why. Nevertheless, the lowest risk for relapse is experienced by those who (1) recover to left ventricular ejection fraction 0.55 prior to another pregnancy; (2) have no deterioration of left ventricular ejection fraction after phasing out angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker treatment following recovery; and perhaps, (3) demonstrate adequate contractile reserve on exercise echocardiography. © 2014, Springer Science+Business Media New York.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Peripartum cardiomyopathy: a rare cause of acute heart failure
    Vogel, Tabea Cornelia Elisabeth
    Schneiter, Stephan
    Fehr, Thomas
    BMJ CASE REPORTS, 2022, 15 (11)
  • [22] Congestive heart failure in postpartum:: A case of peripartum cardiomyopathy
    Merson, L.
    Stecken, L.
    Morel, N.
    Lelias, A.
    Dabadie, P.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2008, 27 (09): : 731 - 734
  • [23] Peripartum cardiomyopathy and acute heart failure associated with prolonged tocolytic therapy in pregnancy A case report
    Li, Pei-Chen
    Chang, Huai-Ren
    Kao, Sheng-Po
    MEDICINE, 2021, 100 (34) : E27080
  • [24] Contemporary Management of Cardiomyopathy and Heart Failure in Pregnancy
    Henrietta Afari
    Megan Sheehan
    Nosheen Reza
    Cardiology and Therapy, 2024, 13 : 17 - 37
  • [25] Contemporary Management of Cardiomyopathy and Heart Failure in Pregnancy
    Afari, Henrietta
    Sheehan, Megan
    Reza, Nosheen
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 17 - 37
  • [26] Peripartum Cardiomyopathy and Hypertensive Pregnancy Subtypes Among 1.6 Million Pregnancies in California Independently Predict Subsequent Incident Myocardial Infarction, Heart Failure, and Stroke
    Arnaout, Rima
    Nah, Gregory
    Marcus, Gregory M.
    Tseng, Zian H.
    Foster, Elyse
    Harris, Ian
    Divanji, Punag
    Olgin, Jeffrey
    Klein, Liviu
    Gonzalez, Juan
    Parikh, Nisha I.
    CIRCULATION, 2016, 134
  • [27] The Treatment of Heart Failure-Related Symptoms with Ivabradine in a Case with Peripartum Cardiomyopathy
    Demir, Serafettin
    Tufenk, Mucahit
    Karakaya, Zeynep
    Akilli, Rabia
    Kanadas, Mehmet
    INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL, 2013, 7 (01) : 33 - 36
  • [28] Peripartum Cardiomyopathy and Hypertensive Pregnancy Subtypes Among 1.6 Million Pregnancies in California Independently Predict Subsequent Incident Myocardial Infarction, Heart Failure, and Stroke
    Arnaout, Rima
    Nah, Gregory
    Marcus, Gregory M.
    Tseng, Zian H.
    Foster, Elyse
    Harris, Ian
    Divanji, Punag
    Olgin, Jeffrey
    Klein, Liviu
    Gonzalez, Juan
    Parikh, Nisha I.
    CIRCULATION, 2016, 134
  • [29] Outcomes of subsequent pregnancy in women with peripartum cardiomyopathy: a systematic review and meta-analysis
    Wijayanto, Matthew Aldo
    Myrtha, Risalina
    Lukas, Graciella Angelica
    Rahma, Annisa Aghnia
    Hanifa, Shafira Nur
    Zahira, Hadiqa Almas
    Ilyas, Muhana Fawwazy
    OPEN HEART, 2024, 11 (01):
  • [30] Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy
    Sliwa, Karen
    van der Meer, Peter
    Petrie, Mark C.
    Frogoudaki, Alexandra
    Johnson, Mark R.
    Hilfiker-Kleiner, Denise
    Hamdan, Righab
    Jackson, Alice M.
    Ibrahim, Bassem
    Mbakwem, Amam
    Tschoepe, Carsten
    Regitz-Zagrosek, Vera
    Omerovic, Elmir
    Roos-Hesselink, Jolien
    Gatzoulis, Michael
    Tutarel, Oktay
    Price, Susanna
    Heymans, Stephane
    Coats, Andrew J. S.
    Mueller, Christian
    Chioncel, Ovidiu
    Thum, Thomas
    de Boer, Rudolf A.
    Jankowska, Ewa
    Ponikowski, Piotr
    Lyon, Alexander R.
    Rosano, Giuseppe
    Seferovic, Petar M.
    Bauersachs, Johann
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04) : 527 - 540